Lessons Learned from Herbal Medicinal Products: The Example of St. John's Wort

被引:107
作者
Nahrstedt, Adolf [1 ]
Butterweck, Veronika [2 ]
机构
[1] Univ Munster, Inst Pharmaceut Biol & Phytochem, D-48149 Munster, Germany
[2] Univ Florida, Coll Pharm, Dept Pharmaceut, Gainesville, FL 32610 USA
来源
JOURNAL OF NATURAL PRODUCTS | 2010年 / 73卷 / 05期
关键词
HYPERICUM-PERFORATUM L; ANTIDEPRESSANT ACTIVITY; PHENOLIC-COMPOUNDS; DRUG-INTERACTIONS; TOTAL EXTRACT; HYPERFORIN; FLAVONOIDS; DEPRESSION; CONSTITUENTS; CYTOKINES;
D O I
10.1021/np1000329
中图分类号
Q94 [植物学];
学科分类号
071001 ;
摘要
The example of St. John's wort offers convincing evidence for the concept that modern methods of pharmacological and phytochemical research are effective in advancing the development of traditional herbal remedies. As a consequence of these efforts, it is known today that several compounds from different structural groups and with different mechanisms of action seem to be responsible for the observed antidepressant efficacy of St. John's Wort. Co-effectors in the extract improve the bioavailability of active constituents such as hypericin (1) (pharmacokinetic synergy). Unwanted side effects are preventable without remarkable loss of activity when the responsible constituent(s) are carefully removed during the extraction process, as demonstrated for hyperforin (3), which is responsible for the induction of cytochrome P450 (CYP)-metabolizing enzymes (CYP3A4, in particular). On the basis of our findings, it is likely that positive interactions between single compounds occur more frequently in traditionally used herbal preparations than is known presently.
引用
收藏
页码:1015 / 1021
页数:7
相关论文
共 50 条
[21]   St. John's Wort for the Treatment of Psychiatric Disorders [J].
Sarris, Jerome .
PSYCHIATRIC CLINICS OF NORTH AMERICA, 2013, 36 (01) :65-+
[22]   Can St. John's wort trigger psychoses? [J].
Stevinson, C ;
Ernst, E .
INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2004, 42 (09) :473-480
[23]   Hyperforin in St. John’s wort drug interactions [J].
Rajanikanth Madabushi ;
Bruno Frank ;
Bernd Drewelow ;
Hartmut Derendorf ;
Veronika Butterweck .
European Journal of Clinical Pharmacology, 2006, 62 :225-233
[24]   Hyperforin in St. John's wort drug interactions [J].
Madabushi, R ;
Frank, B ;
Drewelow, B ;
Derendorf, H ;
Butterweck, V .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 62 (03) :225-233
[25]   St. John's Wort (Hypericum perforatum) Products - How Variable Is the Primary Material? [J].
Scotti, Francesca ;
Lobel, Katja ;
Booker, Anthony ;
Heinrich, Michael .
FRONTIERS IN PLANT SCIENCE, 2019, 9
[26]   St. John's wort and depression - Efficacy, safety and tolerability - an update [J].
Bilia, AR ;
Gallori, S ;
Vincieri, FF .
LIFE SCIENCES, 2002, 70 (26) :3077-3096
[27]   Determination of essential oil and chemical composition of St. John's Wort [J].
Dogan, Hulya ;
Fidan, Hafize ;
Bas, Hatice ;
Stankov, Stanko ;
Stoyanova, Albena ;
Ercisli, Sezai ;
Assouguem, Amine ;
Ullah, Riaz ;
Bari, Ahmed .
OPEN CHEMISTRY, 2024, 22 (01)
[28]   St John's wort (Hypericum perforatum) - a herbal antidepressant [J].
Hippius, H .
CURRENT MEDICAL RESEARCH AND OPINION, 1998, 14 (03) :171-184
[29]   Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.) [J].
E. Ernst ;
J. I. Rand ;
J. Barnes ;
C. Stevinson .
European Journal of Clinical Pharmacology, 1998, 54 :589-594
[30]   Adverse effects profile of the herbal antidepressant St. John's wort (Hypericum perforatum L.) [J].
Ernst, E ;
Rand, JI ;
Barnes, J ;
Stevinson, C .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1998, 54 (08) :589-594